Kate Krav News Today : Breaking News, Live Updates & Top Stories | Vimarsana

These three undervalued stocks have the potential to deliver 6X gains for patient investors who hold them for the long-term.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Blue-chip stocks present a unique opportunity in volitile markets, and we vola...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Earnings reports for S&P 500 stocks have been exceptionally good so far. Here are 10 stocks to buy that have...

7 Old Tech Stocks Plotting a New Tech Comeback InvestorPlace 1 hr ago Everyone loves the disrupters Cathie Wood buys for her ARK Innovation ETF (NYSEARCA: While ARK favorites like Zoom Video (NASDAQ: ZM) look overvalued, investors may be missing some bargains. These companies were big long before the cloud was even a gleam in Amazon (NASDAQ: AMZN) CEO Jeff Bezos’ eye. The fact is that once you’re a tech company, you’re a tech company. Tech stocks with generations of history may be getting left for dead by go-go investors. But there may still be profits in them. I spent the last wee...

Published: Dec 15, 2020 By Krystle Vermes Kate Krav-Rude/Shutterstock Harbour BioMed (HBM)  announced with Utrecht University on Monday that they have licensed their fully human SARS-CoV-2 neutralizing antibody, 47D11, and its program to  . The product is designed for the prevention and treatment of COVID-19, along with related coronaviruses. AbbVie has initiated a Phase I clinical trial of the antibody, and it will conduct the initial clinical program in the U.S. before expanding it into Europe. The antibody targets a specific conserved region of the SARS-CoV-2 spike protein. Pr...